United Therapeutics buy UBS Group AG
Start price
30.06.25
/
50%
€244.10
Target price
30.06.26
€328.48
Performance (%)
45.60%
Price
19.09.25
€355.40
Summary
This prediction is currently active. The BUY prediction by UBS_Group_AG for United Therapeutics has seen massive gains of 45.60%. This prediction currently runs until 30.06.26. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| United Therapeutics | 2.925% | 2.925% |
| iShares Core DAX® | -0.234% | -2.812% |
| iShares Nasdaq 100 | 2.073% | 4.380% |
| iShares Nikkei 225® | 1.244% | 3.620% |
| iShares S&P 500 | 1.133% | 3.104% |
Comments by UBS_Group_AG for this prediction
In the thread United Therapeutics diskutieren
United Therapeutics Corporation (NASDAQ: UTHR) had its price target lowered by analysts at UBS Group AG from $410.00 to $385.00. They now have a "buy" rating on the stock.
Ratings data for UTHR provided by MarketBeat
Stopped prediction by UBS_Group_AG for United Therapeutics
United Therapeutics
Start price
Target price
Perf. (%)
€337.60
04.09.25
04.09.25
€480.20
04.09.26
04.09.26
5.27%
19.09.25
19.09.25
United Therapeutics
Start price
Target price
Perf. (%)
€258.80
13.08.25
13.08.25
€355.41
13.08.26
13.08.26
37.33%
19.09.25
19.09.25
United Therapeutics
Start price
Target price
Perf. (%)
€355.30
08.01.25
08.01.25
€460.94
08.01.26
08.01.26
0.03%
19.09.25
19.09.25
United Therapeutics
Start price
Target price
Perf. (%)
€292.80
08.07.24
08.07.24
€341.51
08.07.25
08.07.25
-14.82%
09.07.25
09.07.25